{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,15]],"date-time":"2026-02-15T09:14:53Z","timestamp":1771146893583,"version":"3.50.1"},"reference-count":13,"publisher":"VM Media SP. zo.o VM Group SK","issue":"6","license":[{"start":{"date-parts":[[2016,11,1]],"date-time":"2016-11-01T00:00:00Z","timestamp":1477958400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"vor","delay-in-days":730,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","oncology-and-radiotherapy.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Reports of Practical Oncology & Radiotherapy"],"published-print":{"date-parts":[[2016,11]]},"DOI":"10.1016\/j.rpor.2016.07.009","type":"journal-article","created":{"date-parts":[[2016,8,24]],"date-time":"2016-08-24T21:32:12Z","timestamp":1472074332000},"page":"495-499","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Low dose palliative radiotherapy for refractory aggressive lymphoma"],"prefix":"10.5603","volume":"21","author":[{"given":"Osamu","family":"Tanaka","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masahiko","family":"Oguchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takayoshi","family":"Iida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Senji","family":"Kasahara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideko","family":"Goto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeshi","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"3595","reference":[{"key":"10.1016\/j.rpor.2016.07.009_bib0065","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/hon.2900120102","article-title":"Potential role for low dose limited-field radiation therapy (2\u00d72 Grays) in advanced low-grade non-Hodgkin's lymphomas","volume":"12","author":"Ganem","year":"1994","journal-title":"Hematol Oncol"},{"key":"10.1016\/j.rpor.2016.07.009_bib0070","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0167-8140(96)01854-3","article-title":"Low dose palliative radiotherapy in low grade non-Hodgkin's lymphoma","volume":"42","author":"Sawyer","year":"1997","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.rpor.2016.07.009_bib0075","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/S0360-3016(01)01626-1","article-title":"A high and sustained response rate in refractory or relapsing low-grade lymphoma masses after low-dose radiation: analysis of predictive parameters of response to treatment","volume":"51","author":"Girinsky","year":"2001","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.rpor.2016.07.009_bib0080","doi-asserted-by":"crossref","first-page":"2474","DOI":"10.1200\/JCO.2003.09.542","article-title":"High response rates and lasting remissions after low-dose involved field radiotherapy in indolent lymphomas","volume":"21","author":"Haas","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.rpor.2016.07.009_bib0085","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1111\/j.1440-1673.2006.01566.x","article-title":"Value of low-dose 2\u00d72Gy palliative radiotherapy in advanced low-grade non-Hodgkin's lymphoma","volume":"50","author":"Ng","year":"2006","journal-title":"Aust Radiol"},{"key":"10.1016\/j.rpor.2016.07.009_bib0090","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1016\/j.ejca.2005.04.033","article-title":"Effective palliation by low dose local radiotherapy for recurrent and\/or chemotherapy refractory non-follicular lymphoma patients","volume":"41","author":"Haas","year":"2005","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.rpor.2016.07.009_bib0095","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1002\/hon.882","article-title":"Low dose radiotherapy in indolent lymphomas, enough is enough","volume":"27","author":"Haas","year":"2009","journal-title":"Hematol Oncol"},{"key":"10.1016\/j.rpor.2016.07.009_bib0100","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1007\/s11604-009-0400-x","article-title":"Palliative radiotherapy with 1\u00d78Gy using conformal radiotherapy for chemotherapy-refractory, recurrent, aggressive lymphomas","volume":"28","author":"Matoba","year":"2010","journal-title":"Jpn J Radiol"},{"key":"10.1016\/j.rpor.2016.07.009_bib0105","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/j.ijrobp.2010.10.013","article-title":"Palliation by low-dose local radiation therapy for indolent non-Hodgkin lymphoma","volume":"81","author":"Chan","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.rpor.2016.07.009_bib0110","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.radonc.2011.05.013","article-title":"Reduced dose radiotherapy for local control in non-Hodgkin lymphoma: a randomised phase III trial","volume":"100","author":"Lowry","year":"2011","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.rpor.2016.07.009_bib0115","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/S1470-2045(14)70036-1","article-title":"4Gy versus 24Gy radiotherapy for patients with indolent lymphoma (FORT): a randomised phase 3 non-inferiority trial","volume":"15","author":"Hoskin","year":"2014","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.rpor.2016.07.009_bib0120","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.ijrobp.2014.09.041","article-title":"Rates and durability of response to salvage radiation therapy among patients with refractory or relapsed aggressive non-Hodgkin lymphoma","volume":"91","author":"Tseng","year":"2015","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"5","key":"10.1016\/j.rpor.2016.07.009_bib2120","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1200\/JCO.2006.09.2403","article-title":"International Harmonization Project on Lymphoma","volume":"25","author":"Cheson","year":"2007","journal-title":"J ClinOncol."}],"container-title":["Reports of Practical Oncology & Radiotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1507136716300712?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1507136716300712?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,2,18]],"date-time":"2021-02-18T14:14:07Z","timestamp":1613657647000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1507136716300712"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11]]},"references-count":13,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2016,11]]}},"alternative-id":["S1507136716300712"],"URL":"https:\/\/doi.org\/10.1016\/j.rpor.2016.07.009","relation":{},"ISSN":["1507-1367"],"issn-type":[{"value":"1507-1367","type":"print"}],"subject":[],"published":{"date-parts":[[2016,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Low dose palliative radiotherapy for refractory aggressive lymphoma","name":"articletitle","label":"Article Title"},{"value":"Reports of Practical Oncology & Radiotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rpor.2016.07.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Greater Poland Cancer Centre. Published by Elsevier Sp. z o.o. All rights reserved.","name":"copyright","label":"Copyright"}]}}